Abstract
Venous thromboembolism (VTE), encompassing deep venous thrombosis (DVT) and pulmonary embolism (PE), remains a significant global health challenge characterized by high morbidity and mortality. Research into the pathogenesis, pathophysiology, and treatment of DVT has evolved significantly, shifting from small murine models to larger animal subjects that more closely mirror human physiology. This study aimed to induce chronic DVT in the left iliac vein of canine and porcine models to evaluate their suitability for long-term therapeutic research. Our findings suggest that large animal models are essential for translating laboratory results into clinical applications, with the canine model demonstrating superior reliability for chronic studies.
Introduction
Translating laboratory breakthroughs into clinical treatments for DVT is notoriously difficult. For decades, researchers relied on small rodent models; however, mice and rats possess vastly different hemodynamics and vessel sizes compared to humans. This makes them poor subjects for testing medical devices such as stents, thrombectomy tools, or novel anticoagulant drugs.
While large animal models like pigs and dogs are better suited for this research, most existing literature focuses on acute (short-term) thrombosis. There is a critical lack of established "chronic" models—those lasting at least 90 days—which are necessary to study post-thrombotic syndrome and long-term vessel obstruction. This study evaluates whether the canine or porcine model serves as the more effective "gold standard" for long-term DVT research.
Methods and Materials
The researchers developed a surgical protocol to induce a solid and immediate thrombus in the left iliac vein of six Labrador dogs and three Bama miniature pigs (all weighing 20–30kg).
- Stenosis Induction: A median abdominal incision was performed to create an 80% narrowing (stenosis) of the vein by ligating it against a glass rod of a specific calculated diameter.
- Chemical Induction: To ensure rapid clot formation, an innovative "cocktail" of thrombin and fibrinogen was injected directly into a 3cm blocked segment of the vein. This method induced a solid thrombus within just 5–7 minutes, significantly faster than traditional methods.
- Post-Operative Care: After two weeks, the animals were administered oral rivaroxaban to mimic standard human clinical care and prevent immediate recurrence while allowing the chronic thrombus to organize.
- Evaluation: Anterograde angiography was performed at 7, 30, 60, and 90 days to track blood flow and collateral vessel growth. At the 90-day mark (or upon premature death), histological staining (HE and Masson) was used to examine the thrombus structure.
Comparative Insights
Anatomical and Surgical Complexity
The study revealed significant differences in surgical feasibility. Porcine anatomy proved more challenging; the inferior vena cava and iliac veins in pigs are encased in dense, fat-filled retroperitoneal tissue. This increased the average surgical duration for pigs to approximately 143 minutes. In contrast, the cleaner anatomy of the canine model allowed for a much more efficient procedure, averaging roughly 74 minutes ($p < 0.01$).
Physiological and Behavioral Factors
A key finding was the impact of animal behavior on recovery. Clinical guidelines for human DVT emphasize the importance of activity to manage recovery and prevent complications. The naturally active and obedient nature of Labrador dogs mirrors this human requirement. Conversely, the Bama miniature pigs were more sedentary, which likely contributed to severe pelvic stasis and poor outcomes.
Collateral Circulation
The canine models developed robust collateral circulation—alternative blood flow channels—by day 60. These side channels successfully bypassed the obstructed iliac vein. In contrast, the porcine models showed very poor collateral growth, leading to high internal pressure and complications.
Key Results
- Survival Rates: The most stark difference was in survival. 100% of the canine group survived the full 90-day study period. In the porcine group, the survival rate was 0%, with animals dying on days 29, 33, and 58 due to complications related to the thrombosis and lack of collateral flow.
- Pathological Consistency: Histological analysis of the canine models at 90 days revealed a classic chronic thrombus structure: a platelet structure composed of collagen fibers, a loss of endothelial cells, and a thickened vessel wall. These findings are highly consistent with human chronic DVT pathology.
- Angiographic Success: In dogs, 90-day follow-up angiography confirmed stable, thick collateral vessels dominating the blood flow, demonstrating a successful transition from an acute blockage to a stable chronic state.
Conclusion and Future Directions
The study concludes that the canine (Labrador) model is significantly more resilient and physiologically appropriate for chronic DVT research than the porcine (Bama miniature pig) model. The dogs' surgical ease, 100% survival rate, and ability to develop collateral circulation make them the preferred choice for testing long-term interventions.
Limitations of this study include the small sample size, particularly in the porcine cohort. Future research should investigate whether a less aggressive stenosis (e.g., 50% instead of 80%) might improve porcine survival rates. Additionally, further study is needed to determine if species-specific sensitivities to anticoagulants like rivaroxaban played a role in the high mortality observed in the pigs.
Summary updated